Page 337 - Avian Virology: Current Research and Future Trends
P. 337

328  |  Coppo et al.

          and single deletion mutants did not reach this same conclusion.   median embryo infective dose (EID ) per bird. Birds typically
                                                                                             50
          The single gI and gE deletion mutants were capable of replicating   develop clinical signs and lesions between 3 and 6 days after
          in cell culture to similar titres of those reached by the wild-type   inoculation, which are accompanied by viral shedding that can be
          parent or rescuant viruses, but produced significantly smaller   detected by PCR or culture using specimens collected from the
          sized plaques, thus confirming its role in cell-to-cell-spread. The   upper respiratory tract (trachea, conjunctiva, palatine cleft) by
          absence of gI did not affect the expression of gE, and vice-versa,   swabbing (in live animals) or scraping off of the mucosal surfaces
          but the absence of both gI and gE had a significant impact on viral   upon post-mortem examination (Fahey  et  al., 1983; Bagust  et
          replication and plaque size. It has been argued that the replica-  al., 1986; Guy et al., 1990; Fuchs et al., 2000; Kirkpatrick et al.,
          tion defect of the first double deletion mutant created by Devlin   2006a; Oldoni et al., 2009). A recent study has shown that the
          et al. (2006a) may have been the result of inadvertent changes in   route of inoculation determines which sites of the upper respira-
          the nucleotide sequences of adjacent genes, especially US6 (gD),   tory tract are infected after inoculation with vaccine or virulent
          which has been found to be indispensable for replication (Pav-  field strain. An interesting observation from this study was that,
          lova et al., 2013). However, analysis of the nucleotide sequences   in contrast with what was observed in other infected tissues,
          upstream to the gI/gE deletion revealed no disruptions in the   microscopic lesions were not apparent in the Harderian gland,
          sequence of US6 in the deletion mutant (Devlin et al., 2006a),   despite the positive detection of viral antigen and genomes in this
          which suggests that replication defects in this mutant may have   tissue, which suggests that Harderian gland may be an important
          originated through changes outside US6. None of the gE or gI   site for virus uptake (Beltrán et al., 2017). During experimental
          deletion recombinants has been investigated in vivo.  acute infection, ILTV not only infects the upper respiratory tract
            Like gD, the protein encoded by US9 has also been categorized   but also undergoes systemic distribution and has been detected
          as a late gene (Mahmoudian et al., 2012; Pavlova et al., 2013) and   by viral isolation in liver and lungs between 5 and 7 days post-
          expressed as two major forms with apparent masses of 37 and   infection (pi) (Bagust et al., 1986), and thymus between 5 and
          25 kDa that are not modified by N-glycosylation (Pavlova et al.,   9 days pi (Oldoni et al., 2009). Using quantitative PCR (qPCR),
          2013). Only trace amounts of this protein are incorporated into   ILTV has also been detected in tissues collected from experi-
          virions and indirect immunofluorescence localized this protein in   mentally inoculated chickens including trigeminal ganglia (4–5
          the cytoplasm of infected cells. An ILTV deletion mutant lacking   days pi), thymus (5–9 days pi), caecal tonsils (4–5 days pi) and
          the US9 ORF was isolated and the absence of this gene did not   sporadically in the cloaca (Oldoni et al., 2009). Later studies
          appear to affect the replication or cell-to-cell spread of the recom-  have found ILTV in almost every organ in the chicken includ-
          binant (Pavlova et al., 2013).                        ing brain, lungs, heart, glandular stomach, spleen, duodenum,
                                                                pancreas, small and large intestine, caecum, kidney, and bursa of
                                                                Fabricius, as early as 1 day pi and as late as 28 days pi (Wang et al.,
          Pathogenesis and immunity                             2013; Zhao et al., 2013), sometimes also causing lesions (Wang
          ILTV infects epithelial cells of the respiratory tract, where it   et al., 2013). Infectious laryngotracheitis virus has also being
          produces a lytic cycle of infection (Calnek et al., 1986). Systemic   detected by PCR and nested qPCR in feather shafts (Davidson
          infections have been described after experimental inoculations,   et al., 2009; Davidson et al., 2016). Although viraemia could not
          where the virus has been detected in tissues outside the respira-  be detected by viral isolation in cell culture (Bagust et al., 1986),
          tory tract (Bagust et al., 1986; Oldoni et al., 2009; Wang et al.,   the identification of ILTV in extra-respiratory tissues indicates
          2013). During acute infection ILTV can infect sensory neurones   that ILTV is systemically distributed. The application of more
          of the peripheral nervous system (Bagust et al., 1986), where the   sensitive molecular detection methods, such as qPCR on blood
          virus establishes a latent infection. Until now only the trachea   samples to detect viraemia, have not been reported in the litera-
          and trigeminal ganglia have been identified as sites of viral latency   ture. It has been hypothesized that monocytes/macrophages may
          (Bagust, 1986; Williams et al., 1992). Reactivation of latent infec-  serve as vehicles for systemic viral spread (Oldoni et al., 2009),
          tion has been described (Hughes et al., 1989, 1991b; Coppo et   as these cells, but not lymphocytes, are permissive to infection
          al., 2012). There is an age-associated susceptibility to ILTV. As   in vitro (Chang et al., 1977; Calnek et al., 1986; Loudovaris et al.,
          birds become more resistant to infection as they grow, they can   1991a,b). However, recent experimental work conducted in our
          withstand infection with increasing doses of ILTV at older ages   laboratories (unpublished) has failed to consistently detect ILTV
          (Fahey et al., 1983).                                 genomes in peripheral blood mononuclear cells (PBMCs) from
                                                                acutely infected chickens, suggesting that ILTV transport may
          Acute infection                                       occur in a different compartment.
          Several chicken experimental infection models of ILT have been   Infection of the trachea with ILTV is normally accompanied
          developed for the study of acute lytic infections, but not for latent   with a reduction of the tracheal luminal diameter, in most cases
          infections. Thus, the features of acute ILTV infection are much   due to diphtheritic lesions in the upper and mid-trachea, com-
          better understood than those associated with latent infection and   monly with caseous plugs in the larynx and upper trachea. Such
          reactivation. Acute experimental infection models utilize inocula-  obstruction in combination with an already rigid structure (chick-
          tions via ocular and/or intra-tracheal route with varying doses of   ens have complete cartilaginous tracheal rings) is responsible for
          viral inoculum, typically ranging from 10  to 10  plaque forming   the respiratory distress observed in diseased chickens (Linares et
                                          2
                                                5
          units (PFU), median tissue culture infective dose (TCID ) or   al., 1994; Bagust et al., 2000) (see ‘Clinical features, diagnosis and
                                                        50
   332   333   334   335   336   337   338   339   340   341   342